Fever and psychosis as an early presentation of brucella-associated meningoencephalitis: A case report

Medical Principles and Practice

Volumn 22, Issue 5, 2013, Pages 506-509

  Montazeri, Mahnaz ^a   Sadeghi, Kourosh ^b   Khalili, Hosein ^b   Davoudi, Setareh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acyclovir; Brucellosis; Hepatotoxicity; Meningoencephalitis; Psychosis

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; COTRIMOXAZOLE; DOXYCYCLINE; RIFAMPICIN; CEFTRIAXONE; GADOLINIUM; IMMUNOGLOBULIN G;

ADULT; AGITATION; ARTICLE; BRUCELLOSIS; CASE REPORT; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; DAIRY PRODUCT; DIETARY INTAKE; FEMALE; FEVER; GRANDIOSE DELUSION; HERPES SIMPLEX VIRUS; HUMAN; HYPERTRANSAMINASEMIA; LIVER TOXICITY; MENINGOENCEPHALITIS; NAUSEA AND VOMITING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; SEROLOGY; TENDON REFLEX; TREATMENT DURATION; VISUAL HALLUCINATION; AGGLUTINATION TEST; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRUCELLA; BRUCELLA ASSOCIATED MENINGOENCEPHALITIS:; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS LEVEL; DELUSION; DISORIENTATION; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HIGH TEMPERATURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LIVER FUNCTION TEST; LUMBAR PUNCTURE; MEDICAL HISTORY; PHYSICAL EXAMINATION; RIGIDITY; TEMPORAL LOBE; UNEMPLOYMENT; VITAL SIGN;

ACYCLOVIR; ADULT; ANTI-BACTERIAL AGENTS; BRAIN; BRUCELLA; DRUG THERAPY, COMBINATION; DRUG-INDUCED LIVER INJURY; FEMALE; FEVER; HUMANS; MENINGOENCEPHALITIS; ORGANIC CHEMICALS; PSYCHOTIC DISORDERS;

EID: 84884290503     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000345640     Document Type: Article

References (10)

1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E: Brucellosis. N Engl J Med 2005; 352: 2325-2336.
2. Hajiabdolbaghi M, Rasoolinejad M, Jafari S, Hasibi M, Soudbakhsh A: Clinical and labaratory findings in neurobrucellosis: review of 31 cases. Arch Iran Med 2008; 11: 21-25.
3. Ghaffarinejad AR, Sarafzadeh F, Sedighi B, Sadeghieh T: Psychosis as an early presentation of neurobrucellosis. Iran J Med Sci 2008; 33: 57-59.
4. Alapin B: Psychosomatic and somato-psychic aspects of brucellosis. J Psychosom Res 1976; 20: 339-350.
5. Eren S, Bayam G, Ergonula O, Celikbas A, Pazvantoglu O, Baykam N, Dokuzoguz B, Dilbaz N: Cognitive and emotional changes in neurobrucellosis. J Infect 2006; 53: 184-189.
6. Karsen H, Akdeniz H, Karahocagil MK, Irmak H, Sünnetçioglu M: Toxic-febrile neurobrucellosis, clinical findings and outcome of treatment of four cases based on our experience. Scand J Infect Dis 2007; 39: 990-995.
7. AL-Sous MW, Bohlega S, AL-Kawi MZ, Alwataban J, Mclean DR: Neurobrucellosis: clinical and neuroimaging correlation. Am J Neuroradiol 2004; 25: 395-401.
8. Abboud G, Kaplowitz N: Drug-induced liver injury. Drug Saf 2007; 30: 277-294.
9. Pratt DS, Kaplan MM: Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-1271.
10. Kaplowitz N: Drug-induced liver injury. Clin Infect Dis 2004; 38(suppl 2):S44-S48.